LORLATINIB (Lorbrena) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the generic name?

LORLATINIB

What is the Trade Name for LORLATINIB?

Lorbrena

What are the Indications for LORLATINIB?

  • 1 INDICATIONS AND USAGE LORBRENA ¬Æ is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test. LORBRENA is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test. ( 1 , 2.1 )

 

View Our Nursing Pharmacology Course


 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.